These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3566488)

  • 1. [Anticonvulsants 5. Substitution reactions in 2,4-dichlo-6-(diallyamino)-1,3,5-triazine systems].
    Kreutzberger A; Schläfer I
    Arch Pharm (Weinheim); 1987 Jan; 320(1):88-90. PubMed ID: 3566488
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticonvulsants. 1. Thiocarbamoylbutyroguanamines].
    Kreutzberger A; Loch M
    Arch Pharm (Weinheim); 1986 Sep; 319(9):769-74. PubMed ID: 3096259
    [No Abstract]   [Full Text] [Related]  

  • 3. A potent, new, sedative--hypnotic agent: 5,7-dihydro-5,5,7,7-tetramethyl-3-(3-nitrophenyl)furo[3,4-e]-as-triazine 4-oxide.
    Bennett GB; Babington RG; Deacon MA; Eden PL; Kerestan SP; Leslie GH; Ryan EA; Mason RB; Minor HE
    J Med Chem; 1981 May; 24(5):490-6. PubMed ID: 7241505
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of 3-[2-(2,3-dihydro-5-phenyl-4-substituted-3H-1,2,4- triazole-3-thione-2-yl)-acetylamino]-2-methyl-4(3H)-quinazolinones and their pharmacological activities.
    Büyüktimkin S; Büyüktimkin N; Ozdemir O; Rollas S
    Arch Pharm (Weinheim); 1989 Jan; 322(1):49-51. PubMed ID: 2567155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on the synthesis and properties of new derivatives of pyrido[3,2-e]-1,3-thiazino[3,2-a]-s-triazine.
    Sladowska H; Bartoszko-Malik A; Zawisza T
    Farmaco Sci; 1985 Jan; 40(1):65-72. PubMed ID: 3979547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diamino-1,3,5 triazine derivatives. VII. Synthesis and various pharmacological properties of 2- amino-4-(3-aminopropyl)-6-(3,5,5-trimethyl- 2-pyrazoline)-1,3,5-triazine].
    Brzozowski Z; Pomarnacka E; Filczewski M; Kosmala M; Oledzka K
    Acta Pol Pharm; 1987; 44(6):481-5. PubMed ID: 3454111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diamino-1,3,5-triazine derivatives. III. Synthesis and diuretic properties of various 2,4-diamino-6-(sulfamylphenyl)-1,3,5-triazines].
    Brzozowski Z; Kamiński Z; Angielski S
    Acta Pol Pharm; 1981; 38(1):1-9. PubMed ID: 7315457
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and in vitro evaluation of 2,4-diamino-1,3,5-triazine derivatives as neuronal voltage-gated sodium channel blockers.
    Ma X; Poon TY; Wong PT; Chui WK
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5644-7. PubMed ID: 19716698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diamino-1,3,5-triazine derivatives. IV. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4-(5-methyl-2-pyrazoline)-1,3,5-triazine derivatives].
    Gajewski F; Rogulski J; Pacanis A
    Acta Pol Pharm; 1983; 40(5-6):537-44. PubMed ID: 6677069
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diamino-1,3,5-triazine derivatives. V. Synthesis and hypoglycemic properties of various 6-amino-1,2-dihydro-4(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine derivatives].
    Gajewski F; Kamiński Z; Pacanis A; Rogulski J
    Acta Pol Pharm; 1983; 40(5-6):545-9. PubMed ID: 6677070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synthesis of s-triazine derivatives of benzimidazole].
    Grzybowski M; Sawlewicz J; Vogel S
    Acta Pol Pharm; 1976; 33(6):673-9. PubMed ID: 1015322
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis of some new trisubstituted derivatives of 2,4,6-trichloro-1,3,5-triazine and their anti-bacterial activity.
    Prakash L; Tyagi E; Shaihla ; Mital RL
    Pharmazie; 1990 Apr; 45(4):284. PubMed ID: 2200065
    [No Abstract]   [Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of hydrazone incorporated 1,2,4-triazines as anticonvulsant agents.
    Amir M; Ali I; Hassan MZ; Mulakayala N
    Arch Pharm (Weinheim); 2014 Dec; 347(12):958-68. PubMed ID: 25251582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant evaluation of clubbed indole-1,2,4-triazine derivatives: a synthetic approach.
    Ahuja P; Siddiqui N
    Eur J Med Chem; 2014 Jun; 80():509-22. PubMed ID: 24813879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and enzymic activity of various substituted pyrazolo[1,5-a]-1,3,5-triazines as adenosine cyclic 3',5'-phosphate phosphodiesterase inhibitors.
    Senga K; O'Brien DE; Scholten MB; Novinson T; Miller JP; Robins RK
    J Med Chem; 1982 Mar; 25(3):243-9. PubMed ID: 6279842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiviral agents. 28. Aliphatic substituted chlordihexylamino-1,3,5-triazine].
    Kreutzberger A; Rose U
    Arzneimittelforschung; 1986 Apr; 36(4):626-9. PubMed ID: 3013214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic antibacterials. I. Nitrofurylvinyl-s-triazine derivatives.
    Nishigaki S; Yoneda F; Matsumoto H; Morinaga K
    J Med Chem; 1969 Jan; 12(1):39-42. PubMed ID: 4973987
    [No Abstract]   [Full Text] [Related]  

  • 18. Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride.
    Baker BR; Ashton WT
    J Med Chem; 1970 Nov; 13(6):1165-70. PubMed ID: 5479858
    [No Abstract]   [Full Text] [Related]  

  • 19. [Derivatives of diamino-1,3,5-triazine. II. Synthesis of some derivative of 2-amino-4-(5-ethyl-4-methyl-2-pyrazoline)-1,3,5-triazine with potential hypoglycemic effect].
    Brzozowski Z; Kozakiewicz I; Pomarnacka E; Kamiński Z
    Acta Pol Pharm; 1980; 37(6):607-13. PubMed ID: 7293805
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anthelmintic agents. 5. Long-chain and hydroheterocyclic-substituted chloro-diallylamino-1,3,5-triazines].
    Kreutzberger A; Schläfer I
    Arch Pharm (Weinheim); 1988 Mar; 321(3):121-4. PubMed ID: 3260475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.